Clinical evaluation of the efficacy of a combination of zanjabeel (Zingiber officinale) and amla (Emblica officinalis) in hyperlipidaemia

Indian Journal of Traditional Knowledge

Volumn 8, Issue 3, 2009, Pages 413-416

  Kamal, Rihana ^a   Aleem, Shagufta ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Amla; Atherosclerosis; Ginger; Hyperlipidaemia; Unani medicine

Indexed keywords

EID: 80355140229     PISSN: 09725938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Anila L & Vijayalakxmi, Flavanoids from Emblica officinalis and Mongifera indica-effectiveness for dyslipidaemia, J Ethnopharmacol, 79 (2002) 81.
2. Boyer Rodney, Concept in Biochemistry, 2nd edition, (The Wadsworth Group Library of Congress, USA), 2002, 506.
3. Brown W, Virgil Niacin for lipid disorders, Post Graduate Med, 98 (1945) 185.
4. Burtis A. Carl & Ashwood R Edward, Tietz Taxtbook of Clinical Chemistry, 3rd edition, (WB Saunders Company, USA), 1999, 809.
5. Cristie M. Ballantyne & Ronc Hoogreen Role of lipids and lipoprotein profile in risk assessment and therapy, Am Heart J, 146 (2003) 228.
6. Gildea EF, Khan E & Man EB, The relationship between body build serum lipid and discussion of these qualities as pyknophilic and liptophilic factor in the structure of personality, Am J Psychiat, (1936) 92 1247.
7. Goodman LS & Gillman A, The pharmacological basis of therapeutics, 7th edition, (Macmillan Publications Company, New York), 1985, 827.
8. Goodman LS & Gillman A, The pharmacological basis of therapeutics, 7th edition, (Macmillan Publications Company, New York), 1985, 827.
9. Han LK, Gang XJ & Kawan OS,. Antiobesity action of Zingiber officinale Rosc., Xakugaku Zasshi, 2005, 125 213.
10. th edition, (Mc Graw Hill Publisher, USA), (1994) 2 2050.
11. James R, Sowers Obesity as a Cardiovascular Risk Factor, Am J Med, Vol & No. (2003) 115 375.
12. John C Larosa & Antonio M Gotto, Past, present and future standards for management of dyslipidaemia, Am J Med, (2004) 115 375.
13. Kirmani Nafees bin Auz, Sharh-e-Asbab wa Alamat, Translated by Hakeem Ayoub Israili, (Munshi Nawal Kishor, Lucknow), 1918, 523.
14. Lawrence M Tierney & Stephen J McPhee, Current Medical Diagnosis, 42nd edition, (Mc Graw Hill Companies, USA), 2003 1199.
15. Majoosi Ali-bin Abbas, Kamilul Sana, Translated by Ghulam Hussain Kintoori, (Munshi Nawal Kishor, Lucknow), 1889, 1, 104.
16. Mansoor Ibne Mohammad, Tashreehul Mansoori, (Mohammadi, Lahore), 1989, 13.
17. Marshal J William, Clinical Chemistry, 3rd Edn, (Butler and Tanner Ltd, London), 1995, 2136.
18. Maseehi Abu-Sehal, Kitabul Maita Maseehi, (Nashrul-uloom Islamic Press, Haidrabad Dakin), 1963, 35, 97, 115.
19. Misra A, Pandey RM, Sinha S & Sridhar V, Receiver operating characteristics curve analysis of body fat and body mass index in dyslipidaemic Asian Indians, Indian J Med Res, 2003, 117 170.
20. Paul Durring, Dislipidaemia, The Lancet, (2003) 362 717.
21. Rafeequddin M, Kanzul Advia Mufrida, (University Publication Unit, AMU, Aligarh), 1985, 55, 78, 114.
22. Scott M Grundy, Low Density Lipoprotein Non-high Density Lipoprotein and Apoprotein B as Targets of Lipid Lowering Therapy, Qtly J Cardiol, 2003, 8 145.
23. Scott M Gundy, David Bilheimer, Henry Blackburn & Virgil Brown, American Heart Association Committee Report, Circulation, 1982, 65 839.
24. Shrinivasan K & Sambaih K, The effect of spices on cholesterol 7-alpha hydroxylase activity and on serum and hepatic cholesterol levels, Int J Vitn Nutr Res, (1991) 61 363.
25. Weatheral DJ, Ledingam JGG & Warell DA, Oxford Text Book of Medicine, International edition, (ELBS Oxford University Press), 1985, 8.
26. Zung VU Tran & Arthur Welfman, Differential effect of exercise on serum lipid and lipoprotein levels seen with change in body weight, JAMA (1985) 254 919.